BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wang J, Lin S, Brown JM, van Wagoner D, Fiocchi C, Rieder F. Novel mechanisms and clinical trial endpoints in intestinal fibrosis. Immunol Rev 2021;302:211-27. [PMID: 33993489 DOI: 10.1111/imr.12974] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Pasztoi M, Ohnmacht C. Tissue Niches Formed by Intestinal Mesenchymal Stromal Cells in Mucosal Homeostasis and Immunity. IJMS 2022;23:5181. [DOI: 10.3390/ijms23095181] [Reference Citation Analysis]
2 Wang Y, Wang Z, Yang H, Chen S, Zheng D, Liu X, Jiang Q, Chen Y. Metformin Ameliorates Chronic Colitis-Related Intestinal Fibrosis via Inhibiting TGF-β1/Smad3 Signaling. Front Pharmacol 2022;13:887497. [DOI: 10.3389/fphar.2022.887497] [Reference Citation Analysis]
3 Fletcher AL, Turley SJ. Who am I? (re-)Defining fibroblast identity and immunological function in the age of bioinformatics. Immunol Rev 2021;302:5-9. [PMID: 34219244 DOI: 10.1111/imr.12993] [Reference Citation Analysis]
4 Lis-López L, Bauset C, Seco-Cervera M, Cosín-Roger J. Is the Macrophage Phenotype Determinant for Fibrosis Development? Biomedicines 2021;9:1747. [PMID: 34944564 DOI: 10.3390/biomedicines9121747] [Reference Citation Analysis]
5 D'Alessio S, Ungaro F, Noviello D, Lovisa S, Peyrin-Biroulet L, Danese S. Revisiting fibrosis in inflammatory bowel disease: the gut thickens. Nat Rev Gastroenterol Hepatol 2021. [PMID: 34876680 DOI: 10.1038/s41575-021-00543-0] [Reference Citation Analysis]